|1.||Latchman, David S: 2 articles (04/2005 - 07/2002)|
|2.||Minowa, Osamu: 1 article (01/2014)|
|3.||Ikeda, Katsuhisa: 1 article (01/2014)|
|4.||Karasawa, Keiko: 1 article (01/2014)|
|5.||Noda, Tetsuo: 1 article (01/2014)|
|6.||Sugitani, Yoshinobu: 1 article (01/2014)|
|7.||Berking, Carola: 1 article (01/2014)|
|8.||Kamiya, Kazusaku: 1 article (01/2014)|
|9.||Kidokoro, Yoshinobu: 1 article (01/2014)|
|10.||Besch, Robert: 1 article (01/2014)|
01/01/2013 - "This study demonstrates that a large number of genes that are activated by NF-κB/Relish in response to infection are normally repressed by the evolutionarily conserved Oct/POU transcription factor Nub. "
04/15/1995 - "The potential regulation of the IE promoters by several different neuronally expressed POU proteins during the initiation, maintenance and re-activation of latent infection in sensory neurons is discussed."
|2.||Breast Neoplasms (Breast Cancer)
06/24/2004 - "Keratinocyte-specific POU transcription factor hSkn-1a represses the growth of cervical cancer cell lines."
12/12/2002 - "Expression of the POU transcription factor Brn-3a is regulated spatially and temporally during embryogenesis and can be detected in a particular subset of neurons and neuronal tumors. "
01/01/2007 - "The importance of POU proteins as developmental regulators and tumor-promoting agents is due to linker flexibility, which allows them to adapt to a considerable variety of DNA targets. "
09/01/2007 - "These cells expressed markers characteristic of pluripotent stem cells, including alkaline phosphatase, stage-specific embryonic antigens (SSEA)-1, SSEA-3, SSEA-4, tumor related antigens (TRA)-1-60, TRA-1-81, and the POU transcription factor Octamer-4 (Oct-4). "
|4.||Melanoma (Melanoma, Malignant)
01/01/2014 - "Here, the POU transcription factor family and its role in melanocytic transformation and melanoma are reviewed. "
12/01/2008 - "Aberrant levels of POU proteins have been found in several malignancies, including melanoma, connecting the otherwise developmentally restricted gene regulatory functions of POU transcription factors to the critical determinants of malignant transformation. "
|5.||Hearing Loss (Hearing Impairment)
|1.||Stage-Specific Embryonic Antigens
|2.||Transcription Factors (Transcription Factor)
|3.||DNA (Deoxyribonucleic Acid)
|6.||stage-specific embryonic antigen-4
|7.||stage-specific embryonic antigen-3 (GL-X)